Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Postoperative Radiotherapy is Associated with Better Survival in Non–Small Cell Lung Cancer with Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base

Postoperative Radiotherapy is Associated with Better Survival in Non–Small Cell Lung Cancer... Original Atricle Postoperative Radiotherapy is Associated with  Better Survival in Non–Small Cell Lung Cancer with  Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base John L. Mikell, MD,*¶ Theresa W. Gillespie, PhD,†‡¶ William A. Hall, MD,*¶ Dana C. Nickleach, MA,§¶ Yuan Liu, PhD,§¶ Joseph Lipscomb, PhD,║¶ Suresh S. Ramalingam, MD,†¶ Raj S. Rajpara, MD,*¶ Seth D. Force, MD,‡¶ Felix G. Fernandez, MD,‡¶ Taofeek K. Owonikoko, MD, PhD,†¶ Rathi N. Pillai, MD,†¶ Fadlo R. Khuri, MD,†¶ Walter J. Curran, MD,*¶ and Kristin A. Higgins, MD*¶ Key Words: Non–small-cell lung cancer, Radiotherapy, PORT, Introduction: Use of postoperative radiotherapy (PORT) in non– Adjuvant therapy. small-cell lung cancer remains controversial. Limited data indicate that PORT may benefit patients with involved N2 nodes. This study (J Thorac Oncol. 2015;10: 462–471) evaluates this hypothesis in a large retrospective cohort treated with chemotherapy and contemporary radiation techniques. Methods: The National Cancer Data Base was queried for patients he use of postoperative radiotherapy (PORT) for resected diagnosed 2004–2006 with resected non–small-cell lung cancer and Tnon–small-cell lung cancer (NSCLC) remains contro- pathologically involved N2 (pN2) nodes also treated with chemo- versial. A large meta-analysis of PORT trials demonstrated therapy. Multivariable Cox proportional hazards model was used to a survival detriment associated with PORT, although subset assess factors http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Postoperative Radiotherapy is Associated with Better Survival in Non–Small Cell Lung Cancer with Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base

Journal of Thoracic Oncology , Volume 10 (3) – Mar 1, 2015

Loading next page...
 
/lp/wolters-kluwer-health/postoperative-radiotherapy-is-associated-with-better-survival-in-non-IIWUtMesnv

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2014 by the International Association for the Study of Lung Cancer
ISSN
1556-0864
DOI
10.1097/JTO.0000000000000411
pmid
25384064
Publisher site
See Article on Publisher Site

Abstract

Original Atricle Postoperative Radiotherapy is Associated with  Better Survival in Non–Small Cell Lung Cancer with  Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base John L. Mikell, MD,*¶ Theresa W. Gillespie, PhD,†‡¶ William A. Hall, MD,*¶ Dana C. Nickleach, MA,§¶ Yuan Liu, PhD,§¶ Joseph Lipscomb, PhD,║¶ Suresh S. Ramalingam, MD,†¶ Raj S. Rajpara, MD,*¶ Seth D. Force, MD,‡¶ Felix G. Fernandez, MD,‡¶ Taofeek K. Owonikoko, MD, PhD,†¶ Rathi N. Pillai, MD,†¶ Fadlo R. Khuri, MD,†¶ Walter J. Curran, MD,*¶ and Kristin A. Higgins, MD*¶ Key Words: Non–small-cell lung cancer, Radiotherapy, PORT, Introduction: Use of postoperative radiotherapy (PORT) in non– Adjuvant therapy. small-cell lung cancer remains controversial. Limited data indicate that PORT may benefit patients with involved N2 nodes. This study (J Thorac Oncol. 2015;10: 462–471) evaluates this hypothesis in a large retrospective cohort treated with chemotherapy and contemporary radiation techniques. Methods: The National Cancer Data Base was queried for patients he use of postoperative radiotherapy (PORT) for resected diagnosed 2004–2006 with resected non–small-cell lung cancer and Tnon–small-cell lung cancer (NSCLC) remains contro- pathologically involved N2 (pN2) nodes also treated with chemo- versial. A large meta-analysis of PORT trials demonstrated therapy. Multivariable Cox proportional hazards model was used to a survival detriment associated with PORT, although subset assess factors

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: Mar 1, 2015

References